Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Measuring Instrument

PUBLISHER: Grand View Research | PRODUCT CODE: 1888710

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1888710

Rapid Pathogen Detection Diagnostics Market Size, Share & Trends Analysis Report By Product, By Technology, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2033

PUBLISHED:
PAGES: 130 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Rapid Pathogen Detection Diagnostics Market Summary

The global rapid pathogen detection diagnostics market size was estimated at USD 21.05 billion in 2024 and is projected to reach USD 30.90 billion by 2033, growing at a CAGR of 4.48% from 2025 to 2033. The growth is driven by growing demand for point-of-care testing, rising awareness and screening programs, as well as increasing product launches and approvals.

The increasing emphasis on early detection and timely intervention in infectious diseases has led healthcare systems to prioritize rapid diagnostic solutions that offer speed, accuracy, and portability. These technologies are becoming essential tools in clinical decision-making, outbreak management, and infection control across hospitals, clinics, and community healthcare settings. For instance, in July 2025, Becton, Dickinson, and Company received U.S. FDA 510(k) clearance for the BD Veritor System for SARS-CoV-2, a digital test designed to detect COVID-19 antigens in symptomatic people in approximately 15 minutes at doctors' offices, urgent care centers, retail clinics, and other convenient points of care.

Moreover, the increasing number of government programs, public health initiatives, and funding efforts aimed at controlling and preventing bacterial diseases are boosting the growth of the rapid pathogen detection diagnostics market. National and international agencies are investing in early detection technologies and point-of-care diagnostic tools to strengthen outbreak preparedness. For instance, in 2024, the WHO announced that, as part of a landmark global health initiative, more than 1.2 million cholera rapid diagnostic test kits were deployed across 14 countries, marking the largest coordinated effort of its kind. This rollout marked the first official implementation of its diagnostic support framework, real-time surveillance, significantly enhancing early detection, and the strategic execution of cholera vaccination campaigns. Thus, the global procurement and distribution program was the result of such collaborative effort among Gavi, WHO, UNICEF, FIND, and other partners committed to strengthening global health security.

Furthermore, the decreasing prices of molecular rapid diagnostic tests for infectious diseases, particularly tuberculosis, are presenting lucrative opportunities for the market. Affordable and accessible diagnostics enable wider adoption in hospitals, clinics, and resource-limited settings, improving early detection and treatment outcomes. For instance, in September 2023, Danaher's (U.S.) subsidiary, Cepheid, announced a reduction in the price of its primary GeneXpert tuberculosis (TB) diagnostic test, lowering it from USD 9.98 to USD 7.97 in response to pressure from TB advocacy groups. The reduction in diagnostic costs is also facilitating the growth of point-of-care testing in decentralized and rural healthcare settings where laboratory infrastructure remains limited. Affordable diagnostics, coupled with continuous technological advancements like automated sample processing and faster turnaround times, are enabling healthcare providers to provide accurate and timely results, which will ultimately strengthen efforts to monitor and control disease. As a result, the downward trend in molecular test prices is helping to lower the morbidity and mortality of infectious diseases worldwide, in addition to increasing market penetration.

Global Rapid Pathogen Detection Diagnostics Market Report Segmentation

This report forecasts revenue growth at the global, regional and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global rapid pathogen detection diagnostics market report based on product, technology, application, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Instruments
  • Rapid Test Kits
  • Consumables & Reagents
  • Software & Connectivity
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Immunoassays
  • Nucleic Acid Amplification Tests (NAAT)
  • Next-Generation Sequencing & Rapid Genotyping
  • Biosensors, Microfluidics & Lab-on-Chip
  • Others (CRISPR)
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Clinical Diagnostics
    • Respiratory Infections
    • Sexually Transmitted Infections (STIs)
    • Bloodborne & Hepatic Infections
    • Gastrointestinal Pathogens
    • Tropical & Vector-Borne Diseases
    • Others
  • Public-health Surveillance & Outbreak Response
  • Food Safety & Environmental Monitoring
  • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Clinical Labs
  • Point-of-Care
  • Public-health Labs
  • Food Testing Labs
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: GVR-4-68040-815-1

Table of Contents

Chapter 1. Rapid Pathogen Detection Diagnostics Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Product
      • 1.1.1.2. Technology Segment
      • 1.1.1.3. Application Segment
      • 1.1.1.4. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Rapid Pathogen Detection Diagnostics Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Product
  • 2.3. Technology Snapshot
  • 2.4. Application Snapshot
  • 2.5. End Use Snapshot
  • 2.6. Competitive Landscape Snapshot

Chapter 3. Rapid Pathogen Detection Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Growing demand for point-of-care testing
    • 3.4.2. Rising awareness and screening programs
    • 3.4.3. increasing product launches and approvals
  • 3.5. Market Restraint Analysis
    • 3.5.1. High cost of advanced technologies
    • 3.5.2. Regulatory hurdles and lengthy approval processes
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis
  • 3.8. Pipeline Analysis

Chapter 4. Rapid Pathogen Detection Diagnostics Market: Product Estimates & Trend Analysis

  • 4.1. Rapid Pathogen Detection Diagnostics Market: Product Movement Analysis
  • 4.2. Instruments
    • 4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3. Rapid Test Kits
    • 4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Consumables & Reagents
    • 4.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Software & Connectivity
    • 4.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Rapid Pathogen Detection Diagnostics Market: Technology Estimates & Trend Analysis

  • 5.1. Rapid Pathogen Detection Diagnostics Market: Technology Movement Analysis
  • 5.2. Immunoassays
    • 5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3. Nucleic Acid Amplification Tests (NAAT)
    • 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Next-Generation Sequencing & Rapid Genotyping
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Biosensors, Microfluidics & Lab-on-Chip
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Others (CRISPER)
    • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Rapid Pathogen Detection Diagnostics Market: Application Estimates & Trend Analysis

  • 6.1. Rapid Pathogen Detection Diagnostics Market: End Use Movement Analysis
  • 6.2. Clinical Diagnostics
    • 6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.2. Respiratory Infections
      • 6.2.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.3. Sexually Transmitted Infections (STIs)
      • 6.2.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.4. Bloodborne & Hepatic Infections
      • 6.2.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.5. Gastrointestinal Pathogens
      • 6.2.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.6. Tropical & Vector-Borne Diseases
      • 6.2.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.7. Others
      • 6.2.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3. Public-health Surveillance & Outbreak Response
    • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Food Safety & Environmental Monitoring
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Others
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Rapid Pathogen Detection Diagnostics Market: End Use Estimates & Trend Analysis

  • 7.1. Rapid Pathogen Detection Diagnostics Market: End Use Movement Analysis
  • 7.2. Hospitals & Clinical Labs
    • 7.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3. Point-of-Care
    • 7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Public-health Labs
    • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Food Testing Labs
    • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Others
    • 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Rapid Pathogen Detection Diagnostics Market: Regional Business Analysis

  • 8.1. Regional Market Snapshot
  • 8.2. North America
    • 8.2.1. North America Rapid Pathogen Detection Diagnostics Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Rapid Pathogen Detection Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.2.2.2. Key Country Dynamics
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. Reimbursement Scenario
      • 8.2.2.5. Competitive Scenario
    • 8.2.3. Canada
      • 8.2.3.1. Canada Rapid Pathogen Detection Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.2.3.2. Key Country Dynamics
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Reimbursement Scenario
      • 8.2.3.5. Competitive Scenario
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Rapid Pathogen Detection Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.2.4.2. Key Country Dynamics
      • 8.2.4.3. Regulatory Framework
      • 8.2.4.4. Reimbursement Scenario
      • 8.2.4.5. Competitive Scenario
  • 8.3. Europe
    • 8.3.1. Europe Rapid Pathogen Detection Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK Rapid Pathogen Detection Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.2.2. Key Country Dynamics
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Reimbursement Scenario
      • 8.3.2.5. Competitive Scenario
    • 8.3.3. Germany
      • 8.3.3.1. Germany Rapid Pathogen Detection Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.3.2. Key Country Dynamics
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Reimbursement Scenario
      • 8.3.3.5. Competitive Scenario
    • 8.3.4. Spain
      • 8.3.4.1. Spain Rapid Pathogen Detection Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.4.2. Key Country Dynamics
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Reimbursement Scenario
      • 8.3.4.5. Competitive Scenario
    • 8.3.5. France
      • 8.3.5.1. France Rapid Pathogen Detection Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.5.2. Key Country Dynamics
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Reimbursement Scenario
      • 8.3.5.5. Competitive Scenario
    • 8.3.6. Italy
      • 8.3.6.1. Italy Rapid Pathogen Detection Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.6.2. Key Country Dynamics
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Reimbursement Scenario
      • 8.3.6.5. Competitive Scenario
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Rapid Pathogen Detection Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.7.2. Key Country Dynamics
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Reimbursement Scenario
      • 8.3.7.5. Competitive Scenario
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Rapid Pathogen Detection Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.8.2. Key Country Dynamics
      • 8.3.8.3. Regulatory Framework
      • 8.3.8.4. Reimbursement Scenario
      • 8.3.8.5. Competitive Scenario
    • 8.3.9. Norway
      • 8.3.9.1. Norway Rapid Pathogen Detection Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.9.2. Key Country Dynamics
      • 8.3.9.3. Regulatory Framework
      • 8.3.9.4. Reimbursement Scenario
      • 8.3.9.5. Competitive Scenario
  • 8.4. Asia Pacific
    • 8.4.1. Asia-Pacific Rapid Pathogen Detection Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan Rapid Pathogen Detection Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.2.2. Key Country Dynamics
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Reimbursement Scenario
      • 8.4.2.5. Competitive Scenario
    • 8.4.3. China
      • 8.4.3.1. China Rapid Pathogen Detection Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.3.2. Key Country Dynamics
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Reimbursement Scenario
      • 8.4.3.5. Competitive Scenario
    • 8.4.4. India
      • 8.4.4.1. India Rapid Pathogen Detection Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.4.2. Key Country Dynamics
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Reimbursement Scenario
      • 8.4.4.5. Competitive Scenario
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea Rapid Pathogen Detection Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.5.2. Key Country Dynamics
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Reimbursement Scenario
      • 8.4.5.5. Competitive Scenario
    • 8.4.6. Thailand
      • 8.4.6.1. Thailand Rapid Pathogen Detection Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.6.2. Key Country Dynamics
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Reimbursement Scenario
      • 8.4.6.5. Competitive Scenario
    • 8.4.7. Australia
      • 8.4.7.1. Australia Rapid Pathogen Detection Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.7.2. Key Country Dynamics
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Reimbursement Scenario
      • 8.4.7.5. Competitive Scenario
  • 8.5. Latin America
    • 8.5.1. Latin America Rapid Pathogen Detection Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Rapid Pathogen Detection Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.5.2.2. Key Country Dynamics
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Reimbursement Scenario
      • 8.5.2.5. Competitive Scenario
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina Rapid Pathogen Detection Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.5.3.2. Key Country Dynamics
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Reimbursement Scenario
      • 8.5.3.5. Competitive Scenario
  • 8.6. MEA
    • 8.6.1. MEA Rapid Pathogen Detection Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa Rapid Pathogen Detection Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.6.2.2. Key Country Dynamics
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Reimbursement Scenario
      • 8.6.2.5. Competitive Scenario
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Saudi Arabia Rapid Pathogen Detection Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.6.3.2. Key Country Dynamics
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Reimbursement Scenario
      • 8.6.3.5. Competitive Scenario
    • 8.6.4. UAE
      • 8.6.4.1. UAE Rapid Pathogen Detection Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.6.4.2. Key Country Dynamics
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Reimbursement Scenario
      • 8.6.4.5. Competitive Scenario
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Rapid Pathogen Detection Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.6.5.2. Key Country Dynamics
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Reimbursement Scenario
      • 8.6.5.5. Competitive Scenario

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
    • 9.2.1. New Product Launch
    • 9.2.2. Partnerships
    • 9.2.3. Acquisition
    • 9.2.4. Collaboration
    • 9.2.5. Funding
  • 9.3. Key Company Market Share Analysis, 2024
  • 9.4. Company Heat Map Analysis
  • 9.5. Company Profiles
    • 9.5.1. F. Hoffmann-La Roche Ltd
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. Thermo Fisher Scientific Inc.
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3. BIOMERIEUX
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic Initiatives
    • 9.5.4. Danaher Corporation
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. DiaSorin
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. Becton, Dickinson and Company (BD)
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic Initiatives
    • 9.5.7. QIAGEN
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic Initiatives
    • 9.5.8. Siemens Healthineers AG
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic Initiatives
    • 9.5.9. PerkinElmer
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic Initiatives
    • 9.5.10. Illumina, Inc.
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic Initiatives
    • 9.5.11. Agilent Technologies, Inc.
      • 9.5.11.1. Company Overview
      • 9.5.11.2. Financial Performance
      • 9.5.11.3. Product Benchmarking
      • 9.5.11.4. Strategic Initiatives
    • 9.5.12. Bio-Rad Laboratories, Inc.
      • 9.5.12.1. Company Overview
      • 9.5.12.2. Financial Performance
      • 9.5.12.3. Product Benchmarking
      • 9.5.12.4. Strategic Initiatives
    • 9.5.13. Eurofins Scientific
      • 9.5.13.1. Company Overview
      • 9.5.13.2. Financial Performance
      • 9.5.13.3. Product Benchmarking
      • 9.5.13.4. Strategic Initiatives
    • 9.5.14. Charles River Laboratories
      • 9.5.14.1. Company Overview
      • 9.5.14.2. Financial Performance
      • 9.5.14.3. Product Benchmarking
      • 9.5.14.4. Strategic Initiatives
Show more
Product Code: GVR-4-68040-815-1

List of Tables

  • Table 1 List Of Secondary Sources
  • Table 2 List Of Abbreviation
  • Table 3 Global Rapid Pathogen Detection Diagnostics Market, By Region, 2021 - 2033 (USD Million)
  • Table 4 Global Rapid Pathogen Detection Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 5 Global Rapid Pathogen Detection Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 6 Global Rapid Pathogen Detection Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 7 Global Rapid Pathogen Detection Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 8 North America Rapid Pathogen Detection Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 9 North America Rapid Pathogen Detection Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 10 North America Rapid Pathogen Detection Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 11 North America Rapid Pathogen Detection Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 12 North America Rapid Pathogen Detection Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 13 U.S. Rapid Pathogen Detection Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 14 U.S. Rapid Pathogen Detection Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 15 U.S. Rapid Pathogen Detection Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 16 U.S. Rapid Pathogen Detection Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 17 Canada Rapid Pathogen Detection Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 18 Canada Rapid Pathogen Detection Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 19 Canada Rapid Pathogen Detection Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 20 Canada Rapid Pathogen Detection Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 21 Mexico Rapid Pathogen Detection Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 22 Mexico Rapid Pathogen Detection Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 23 Mexico Rapid Pathogen Detection Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 24 Mexico Rapid Pathogen Detection Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 25 Europe Rapid Pathogen Detection Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 26 Europe Rapid Pathogen Detection Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 27 Europe Rapid Pathogen Detection Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 28 Europe Rapid Pathogen Detection Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 29 Europe Rapid Pathogen Detection Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 30 UK Rapid Pathogen Detection Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 31 UK Rapid Pathogen Detection Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 32 UK Rapid Pathogen Detection Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 33 UK Rapid Pathogen Detection Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 34 Germany Rapid Pathogen Detection Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 35 Germany Rapid Pathogen Detection Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 36 Germany Rapid Pathogen Detection Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 37 Germany Rapid Pathogen Detection Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 38 France Rapid Pathogen Detection Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 39 France Rapid Pathogen Detection Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 40 France Rapid Pathogen Detection Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 41 France Rapid Pathogen Detection Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 42 Italy Rapid Pathogen Detection Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 43 Italy Rapid Pathogen Detection Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 44 Italy Rapid Pathogen Detection Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 45 Italy Rapid Pathogen Detection Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 46 Spain Rapid Pathogen Detection Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 47 Spain Rapid Pathogen Detection Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 48 Spain Rapid Pathogen Detection Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 49 Spain Rapid Pathogen Detection Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 50 Sweden Rapid Pathogen Detection Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 51 Sweden Rapid Pathogen Detection Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 52 Sweden Rapid Pathogen Detection Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 53 Sweden Rapid Pathogen Detection Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 54 Norway Rapid Pathogen Detection Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 55 Norway Rapid Pathogen Detection Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 56 Norway Rapid Pathogen Detection Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 57 Norway Rapid Pathogen Detection Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 58 Denmark Rapid Pathogen Detection Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 59 Denmark Rapid Pathogen Detection Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 60 Denmark Rapid Pathogen Detection Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 61 Denmark Rapid Pathogen Detection Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Rapid Pathogen Detection Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Rapid Pathogen Detection Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Rapid Pathogen Detection Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 65 Asia-Pacific Rapid Pathogen Detection Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 66 Asia Pacific Rapid Pathogen Detection Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 67 Japan Rapid Pathogen Detection Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 68 Japan Rapid Pathogen Detection Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 69 Japan Rapid Pathogen Detection Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 70 Japan Rapid Pathogen Detection Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 71 China Rapid Pathogen Detection Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 72 China Rapid Pathogen Detection Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 73 China Rapid Pathogen Detection Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 74 China Rapid Pathogen Detection Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 75 India Rapid Pathogen Detection Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 76 India Rapid Pathogen Detection Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 77 India Rapid Pathogen Detection Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 78 India Rapid Pathogen Detection Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 79 Australia Rapid Pathogen Detection Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 80 Australia Rapid Pathogen Detection Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 81 Australia Rapid Pathogen Detection Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 82 Australia Rapid Pathogen Detection Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 83 Thailand Rapid Pathogen Detection Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 84 Thailand Rapid Pathogen Detection Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 85 Thailand Rapid Pathogen Detection Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 86 Thailand Rapid Pathogen Detection Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 87 South Korea Rapid Pathogen Detection Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 88 South Korea Rapid Pathogen Detection Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 89 South Korea Rapid Pathogen Detection Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 90 South Korea Rapid Pathogen Detection Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 91 Latin America Rapid Pathogen Detection Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 92 Latin America Rapid Pathogen Detection Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 93 Latin America Rapid Pathogen Detection Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 94 Latin America Rapid Pathogen Detection Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 95 Latin America Rapid Pathogen Detection Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 96 Brazil Rapid Pathogen Detection Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 97 Brazil Rapid Pathogen Detection Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 98 Brazil Rapid Pathogen Detection Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 99 Brazil Rapid Pathogen Detection Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 100 Argentina Rapid Pathogen Detection Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 101 Argentina Rapid Pathogen Detection Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 102 Argentina Rapid Pathogen Detection Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 103 Argentina Rapid Pathogen Detection Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 104 MEA Rapid Pathogen Detection Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 105 MEA Rapid Pathogen Detection Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 106 MEA Rapid Pathogen Detection Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 107 MEA Rapid Pathogen Detection Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 108 MEA Rapid Pathogen Detection Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 109 South Africa Rapid Pathogen Detection Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 110 South Africa Rapid Pathogen Detection Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 111 South Africa Rapid Pathogen Detection Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 112 South Africa Rapid Pathogen Detection Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia Rapid Pathogen Detection Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia Rapid Pathogen Detection Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia Rapid Pathogen Detection Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 116 Saudi Arabia Rapid Pathogen Detection Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 117 UAE Rapid Pathogen Detection Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 118 UAE Rapid Pathogen Detection Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 119 UAE Rapid Pathogen Detection Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 120 UAE Rapid Pathogen Detection Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 121 Kuwait Rapid Pathogen Detection Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 122 Kuwait Rapid Pathogen Detection Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 123 Kuwait Rapid Pathogen Detection Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 124 Kuwait Rapid Pathogen Detection Diagnostics Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global rapid pathogen detection diagnostics market- Key market driver analysis
  • Fig. 7 Global rapid pathogen detection diagnostics market - Key market restraint analysis
  • Fig. 8 Penetration & growth prospect mapping
  • Fig. 9 Global rapid pathogen detection diagnostics market - Porter's analysis
  • Fig. 10 Global rapid pathogen detection diagnostics market - PESTEL analysis
  • Fig. 11 Global rapid pathogen detection diagnostics market: Product outlook key takeaways
  • Fig. 12 Global rapid pathogen detection diagnostics market: Product movement analysis
  • Fig. 13 Instruments market estimates, 2021 - 2033 (USD Million)
  • Fig. 14 Rapid test kits market estimates, 2021 - 2033 (USD Million)
  • Fig. 15 consumables & reagents market estimates, 2021 - 2033 (USD Million)
  • Fig. 16 software & connectivity market estimates, 2021 - 2033 (USD Million)
  • Fig. 17 Global rapid pathogen detection diagnostics market: Technology outlook key takeaways
  • Fig. 18 Global rapid pathogen detection diagnostics market: Technology movement analysis
  • Fig. 19 Immunoassays market estimates, 2021 - 2033 (USD Million)
  • Fig. 20 Nucleic acid amplification tests (NAAT) market estimates, 2021 - 2033 (USD Million)
  • Fig. 21 Next-Generation sequencing & rapid genotyping market estimates, 2021 - 2033 (USD Million)
  • Fig. 22 Biosensors, microfluidics & lab-on-chip market estimates, 2021 - 2033 (USD Million)
  • Fig. 23 Others (CRISPR) market estimates, 2021 - 2033 (USD Million)
  • Fig. 24 Global rapid pathogen detection diagnostics market: Application outlook key takeaways
  • Fig. 25 Global rapid pathogen detection diagnostics market: Application movement analysis
  • Fig. 26 Clinical diagnostics market estimates, 2021 - 2033 (USD Million)
  • Fig. 27 Respiratory infections market estimates, 2021 - 2033 (USD Million)
  • Fig. 28 Sexually transmitted infections (STIS) market estimates, 2021 - 2033 (USD Million)
  • Fig. 29 Bloodborne & hepatic infections market estimates, 2021 - 2033 (USD Million)
  • Fig. 30 Gastrointestinal pathogens market estimates, 2021 - 2033 (USD Million)
  • Fig. 31 Tropical & vector-borne diseases market estimates, 2021 - 2033 (USD Million)
  • Fig. 32 Others market estimates, 2021 - 2033 (USD Million)
  • Fig. 33 Public-health surveillance & outbreak response market estimates, 2021 - 2033 (USD Million)
  • Fig. 34 Food safety & environmental monitoring market estimates, 2021 - 2033 (USD Million)
  • Fig. 35 Others market estimates, 2021 - 2033 (USD Million)
  • Fig. 36 Global rapid pathogen detection diagnostics market: End Use outlook key takeaways
  • Fig. 37 Global rapid pathogen detection diagnostics market: End Use movement analysis
  • Fig. 38 Hospitals & clinical labs market estimates, 2021 - 2033 (USD Million)
  • Fig. 39 Point-of-care market estimates, 2021 - 2033 (USD Million)
  • Fig. 40 Public-health labs market estimates, 2021 - 2033 (USD Million)
  • Fig. 41 Food testing labs market estimates, 2021 - 2033 (USD Million)
  • Fig. 42 Others market estimates, 2021 - 2033 (USD Million)
  • Fig. 43 Regional marketplace: Key takeaways
  • Fig. 44 Global rapid pathogen detection diagnostics market: Regional movement analysis
  • Fig. 45 North America rapid pathogen detection diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 46 U.S. rapid pathogen detection diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 47 Canada rapid pathogen detection diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 48 Mexico rapid pathogen detection diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 49 Europe rapid pathogen detection diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 50 UK rapid pathogen detection diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 51 Germany rapid pathogen detection diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 52 France rapid pathogen detection diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 53 Spain rapid pathogen detection diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 54 Italy rapid pathogen detection diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 55 Denmark rapid pathogen detection diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 56 Sweden rapid pathogen detection diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 57 Norway rapid pathogen detection diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 58 Asia Pacific rapid pathogen detection diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 59 Japan rapid pathogen detection diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 60 China rapid pathogen detection diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 61 India rapid pathogen detection diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 62 South Korea rapid pathogen detection diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 63 Australia rapid pathogen detection diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 64 Thailand rapid pathogen detection diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 65 Latin America rapid pathogen detection diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 66 Brazil rapid pathogen detection diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 67 Argentina rapid pathogen detection diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 68 MEA rapid pathogen detection diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 69 South Africa rapid pathogen detection diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 70 Saudi Arabia rapid pathogen detection diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 71 UAE rapid pathogen detection diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 72 Kuwait rapid pathogen detection diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 73 Strategy framework
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!